Somatostatin-14 (SS-14) was first discovered as an inhibitor of growth hormone secretion. It has since been shown to regulate brain and gut function by paracrine mechanisms (1, 2) . SS-14 inhibits adenylate cyclase activity in isolated rat hepatocytes and liver (3, 4) . It also inhibits glycogenolysis and very low density lipoprotein production in the isolated, perfused rat liver (5, 6) . Taken together, the data suggest the existence of a direct effect of SS-14 on the liver, possibly receptor-mediated (7) . SS-14 binding to liver has been reported previously (8) . One study using an SS-14 analog showed binding to the liver cell plasma membrane (9), whereas other studies using a dynamic dilution technique demonstrated 9.8% binding that could not be displaced by synthetic SS-14 (10). In this report, we identified and characterized SS-14 binding sites on rat liver plasma membranes using a conventional direct binding assay and biochemical characterization with a variety of standard techniques.
MATERIALS AND METHODS
Chemicals. All protease inhibitors, sugars, agarose, wheat germ agglutinin WGA) and endo-P-N-acetylglucosaminidase F (endo F) were obtained from Sigma Chemical Co. (St. Louis, MO). SS-14, [tyr"]SS-14 and all other peptides were obtained from Peninsula Laboratories (Belmont, CA). Disuccimidyl suberate (DSS) and other cross-linking reagents were obtained from Pierce Chemical (Rockford, IL). All reagents used in SDS-PAGE were of electrophoresis grade and were obtained from Bio-Rad Laboratories (Richmond, CAI or from Boehringer-Mannheim (Indianapolis, IN). Radioactive sodium iodide for the radioiodination of [tyr1'ISS-14 was obtained from Amersham (Arlington Heights, IL). 5'-Nucleotidase, aklaline phosphatase and total protein were assayed with commercial kits obtained from Sigma Chemical Co. Rat liver plasma membranes were prepared from the livers of adult male Sprague-Dawley rats (250 to 275 gm) (11) . Rat liver was homogenized with 10 strokes in a Dounce tissue homogenizer (Sigma Chemical Co.) containing 50 ml ice-cold buffer (0.5 mmol/L CaCl,, 1 mmol/L NaHCO,, 2 p,mol/L leupeptin, 2 &morn pepstatin, 1 &mol/L PMSF and 0.1 m g / d bacitracin at pH 7.5). After three low-speed centrifugations (2,500 rpm), the crude preparation was pooled in a 50-ml ultracentrifuge tube and spun through a discontinuous sucrose density gradient for 2 hr at 25,000 rpm and at 4" C. The liver plasma membranes 433 434 RAPER, KOTHARY AND DELVALLE HEPATOLOGY layered at the interface of 37% and 41% sucrose. The plasma membrane fraction collected from the interface was then stored at -70" C. Two separate membrane enzyme analyses-5'-nucleotidase and alkaline phosphatase-were performed in the crude homogenate and the final membrane preparation (11) . Membranes were accepted as pure, with at least a 20-fold increase in enzyme activity per milligram wet weight. Membranes were used immediately or suspended in 50 mmol/L HEPES buffer (pH 7.4); aliquots were kept at -70" C until ready for use.
Binding Assay. Radiolabeling of the SS-14 analog [tyr1'1SS-14 was performed as described previously with chloramine-T (12). [tyr"]SS-14 (2.4 nmol), lz5NaI (0.5 mCi) and chloramine-T were incubated in 0.04 m o m sodium phosphate buffer in a final reaction volume of 100 ~1 .
The specific activity of the tracer was -1,000 Ci/mmol. The radioligand was purified by reverse-phase HPLC on a FBondapak C18 column (0.39 x 30 cm; Waters Associates, Milford, MA). Elution buffer A was 2% trifluoroacetic acid and buffer B was 2% trifluoroacetic acid with 50% acetonitrile. The column was eluted at a flow rate of 1 mVmin at room temperature with a protocol of 5 rnin at 0% buffer B, 17.5 min gradient of 0% to 70% buffer B, 10 min at 70% buffer B and 70% to 0% buffer B (13) .
Binding of 1251-[tyr1']SS-14 (50 pmol/L) to plasma membrane (20 pg/ml) was carried out in 0.5 ml of binding buffer (1 mmol/L NaHCO,, 0.5 mmoVL CaCl,, 2 pmol/L leupeptin, 2 Fmol/L pepstatin, 1 mmol/L PMSF and 0.1 mg/ml bacitracin) and increasing concentrations of synthetic peptides or nucleotides at pH 7.5 for 50 rnin at 24" C. When the incubation temperature was decreased to 4" C, no significant specific binding was seen, but a decrease in maximal binding at 37" C did appear. Membrane-bound 1251-[tyr11]SS-14 was separated by centrifugation at 10,000 g for 15 min at 4" C and washed with fresh binding buffer. Pellet radioactivity was monitored with a gamma counter. Binding to liver plasma membranes in the presence of 10 FmoVL SS-14 was considered nonspecific binding. The elution profile of the binding assay supernatant was obtained on a Sephadex G-50 Superfine (100 cm x 1 cm) chromatography column (LKB-Pharmacia, Piscataway, NJ) in 1 M glacial acetic acid as described (14) . Stability of 1251-[tyr"]SS-14 incubated for 50 min with membranes was 92%-identical to stability of '261-[tyr11]SS-14 incubated in the absence of rat liver plasma membranes.
M n i t y Cross-Linking Protocol. Fifty micrograms of rat liver plasma membranes were incubated in 0.5 ml of binding buffer in the presence or absence of SS-14 with lZ5I-[tyr'']SS-14 (150 pmol/L) for 50 rnin at 24" C (15) . In some experiments, we used 10 Fg membranes and '251-[tyr1'lSS-14 (30 pmol/L). The mixture was centrifuged at 10,000 g for 15 min at 4" C. The pellet was washed in 1.0 ml of ice-cold binding buffer and recentrifuged for 10 min at 10,000 g and 4" C. Three heterobifunctional cross-linking reagents -Nhydroxysuccinimidyl4-azidobenzoate (HSAB), N-succinimidyl 6-(azido-2'-nitrophenylamine) hexanoate (SAN-PAH) and N-(5-azido-2'-nitrobenzoyloxy)-succinimide (ANB-NOS) -were used. The heterobifunctional photoreactive cross-linking reagents were freshly dissolved in DMSO and added at a 1 : 100 dilution to a final concentration of 100 FmoVL to the resuspended pellet. Membrane suspensions were then transferred to 16-mm Costar plates (Costar, Cambridge, MA) and exposed to UV light (275-W sunlamp) at a distance of 15 cm for 15 rnin at 4" C. Ice-cold buffer containing 2 mmol/L EDTA was added, and membranes were pelleted. The homobifunctional cross-linking reagent DSS was dissolved in DMSO and added at a 1 : 100 dilution to a final concentration of 1 mmol/L. The reaction was allowed to proceed for 20 min at 4" C and then quenched with 1 (17) . Samples were subjected to electrophoresis in 7.5% or 12% acrylamide and 1% SDS. The gels were fixed and dried; autoradiography was performed on dried gels by exposing them to Kodak X-Omat AR film (Eastman Kodak Co., Rochester, NY) with an enhancing screen at -70" C. A cross-linking efficiency of 1% to 2% was demonstrated by cutting the lanes on some dried gels into 0.5-cm blocks, then measuring each block for radioactivity in a gamma counter.
Plasma Membrane Solubilization. Affinity-labeled membranes (1 mg/ml) were solubilized in 50 mmol/L Tris-HC1 and 0.5 mmol/L benzamidine buffer containing 1% concentrations of Zwittergent 3-12 (Calbiochem, La Jolla, CAI, 3-([3-~holamidopropyl] dimethy1ammonio)-1-propanesulfonic acid (CHAPS), digitonin or Triton X-100. After gentle agitation for 30 min, the solubilized, affinity-labeled membranes were subjected to centrifugation at 100,OOOg for 60 rnin at 4" C (15). Supernatant radioactivity was counted in a gamma counter and expressed as counts per minute per milligram of protein.
WGA Adsorption Chromatography. Ten milligrams of WGA-agarose beads in 1.0 ml of 1.0 moVL NaCl was packed into a 10 x 0.7 cm column and washed with 40 ml Tris-HCl(50 mmol/L) containing 1% Zwittergent 3-12. Solubilized, affinitylabeled complexes were prepared as described above, and the supernatant was applied to the WGA-agarose column (Sigma Chemical Co.). The columns were washed with Ca' + buffer until they were free of detectable radioactivity. The column was then washed with 4 mmol/L N, N', N-triacetylchitotriose in buffer containing 1% Zwittergent 3-12. Two-milliliter fractions were collected, and radioactivity was assayed in a gamma counter (15) .
Hydrolysis of Glycoproteins. Hydrolysis of DSS (Pierce Chemical Co., Rockford, IL) cross-linked 1251-[tyr'1]SS-14 binding protein complexes in a volume of 0.1 ml containing 1 unit of endo F, 1% Zwittergent 3-12 and 20 mmol/L EDTA in 0.25 m o m sodium acetate was performed at 37" C for 1 hr (18, 19) . The resulting reaction product was pelleted by centrifugation at 2,500 rpm and subjected to SDS-PAGE; this was followed by silver staining and gel autoradiography.
Statistical Analysis. For binding analysis, a multiplevariable curve-fitting program was developed after the method of Munson and Rodbard (20) . Scatchard analysis was performed by plotting boundfree ligand vs. bound ligand.
Ethical Considerations. The study protocol was approved by the University of Michigan Committee on Use and Care of Animals.
RESULTS
Characterization of SS-14 Binding to Liver Plasma Membranes. Specific binding of 1261-[tyr'11SS-14 to the rat liver plasma membrane preparation was time dependent. Steady-state binding to the liver plasma membranes reached a plateau by 50 min (Fig. 1A) . At maximal specific binding, nonspecific binding was 30% to 40% of total binding. The addition of synthetic SS-14 induced rapid dissociation of the bound radioactivity (Fig. 1B) . The presence of 0.5 mmol/L CaC1, was found to be necessary because no specific binding was observed in the absence of calcium (data not shown). Increasing concentrations of synthetic SS-14 inhibited the binding of 1261-[tyr11]SS-14 to the liver plasma membranes and resulted in a characteristic competition binding profile (Fig. 2) . This binding data was transformed into a Scatchard plot indicating the presence of a single class of high-afhity binding sites with an affinity constant (K,) of 2.4 k 0.2 nmoUL and a binding capacity (Bmm) of 148 k 0.02 fmoVmg protein (Fig. 2, inset) .
The specific binding of 1251-[tyr111SS-14 to rat liver plasma membranes was further investigated with several synthetic analogs of SS-14. The biologically gastrin, motilin and gastrin-releasing peptide were unable to displace 1261-[tyr1']SS-14 (Table 1) .
Covalent Cross-linking of 1261-[tyr]11SS-14 to Its
Binding Protein. To study the biochemical nature and molecular weight of the binding protein, 1251-
[tyP]SS-14 was incubated with the plasma membranes; the bound complex was then covalently crosslinked. One homobifunctional cross-linking reagent, DSS, and three heterobifunctional cross-linking reagents -HSAB, SAN-PAH and ANB-NOS -were used. DSS was found to be the most efficient. Among the three heterobifunctional cross-linking reagents, ANB-NOS was the most efficient ( Table 2) . The crosslinking efficiency was 1% to 2%, in agreement with the work of Susini et al. (15 solubilized at a concentration of 1 mg/ml with 1% detergent for 2 hr at 4" C. After centrifugation, the supernatant was aspirated, and radioactivity was quantitated (at least four experiments per reagent).
Data expressed as mean * S.E.M. presence of this band was eliminated by the addition of 10 pmolL SS-14 during cross-linking (Fig. 3) . Addition of 50 mmoVL DTT did not alter the position or number of protein bands at mol wt 70,000 Da (Fig. 3 ) .
Solubilization of Cross-linked Binding Protein Complexes in Nondemturing Detergents. To further characterize the SS-14 binding protein, it was necessary to solubilize the labeled complex in nondenaturing detergents. To investigate the solubility of the binding protein, 1% solutions of four detergents (Zwittergent 3-12, CHAPS, digitonin and Triton X-100) were used.
Specific binding sites were saturated with '"I-[tyrl1]SS-14 (150 pmol/L) and then cross-linked with DSS. Increased labeling was not associated with increased nonspecific binding. Of the four detergents used, Zwittergent 3-12 and CHAPS were associated with essentially complete solubilization of the labeled complexes ( Table 3) . plateau, buffer containing 4 mmol/L N, N', N"-triacetylchitotriose was added and an additional radioactive peak was eluted (Fig. 4) .
Treatment of DSS cross-linked '251-[tyr"lSS-14 binding protein complexes with endo F before WGA column chromatography resulted in loss of binding (Fig.  5) . The decrease in the amount of noncovalent crosslinked radioactivity that eluted in the initial two fractions in the control sample in comparison to Figure 4 reflects an extra wash with buffer. Although deglycosylation by endo F of DSS cross-linked 1251-[tyr1'3SS-14 binding proteins abolished binding to WGA-agarose columns, no significant alteration in migration on SDS-PAGE autoradiography could be noted (Fig. 6 ) .
E.ysTeet of Nucle0tid.e~ on the Binding of 1261-[tyr1'lSS-14. A well-known characteristic of binding proteins documented to be receptors is the demonstration of coupling to G proteins and regulation by guanine nucleotides (16) . We investigated the effects of several nucleotides on 1251-[tyr11]SS-14 binding to liver plasma membranes (Fig. 7 A,B) . The specific binding of 1261-[tyr"]SS-14 was inhibited by GTP and GDP with approximately equal potency, whereas GMP did not inhibit specific binding (Fig. 7A) . The addition of pyruvate b e and phosphoenol pyruvate to regenerate GTP from GDP increased the inhibition of binding, indicating that the membrane preparation can hydrolyse GTP. In each experiment, care was taken to adjust the pH in an attempt to prevent acidic dissociation of 1261-[tyr1'JSS-14 to the membrane protein.
We further compared the effects of GTP with the nonhydrolyzable GTP analog guanosine-5'-0-(3-thiotriphosphate) (GTP-yS) and ATP on the binding of '261-[tyr111SS-14 to the liver plasma membranes. Liver plasma membranes were incubated at tions of GTP, GTPyS and ATP; again, care was taken to adjust the pH. GTP and GTPyS inhibited the binding of 1251-[tyr11]SS-14 in a dose-dependent manner (Fig. 7B) . The binding of 1251-[tyr111SS-14 appeared to be specifically decreased by guanine nucleotides because mom ATP had only an attenuated effect.
DISCUSSION
In this study, we demonstrated the presence of specific binding sites for iodinated SS-14 on rat liver plasma membranes. Specific binding was time dependent, saturable and reversible. The calculated affmity of 2.4 n m o n is similar to that of other sites in the gastrointestinal tract, specifically the stomach and pancreas (12, 16, 17) . Our finding of the need for Ca+ + in the binding buffer for iodinated SS-14 to specifically bind to liver plasma membranes is in agreement with that reported for SS-14 binding to its receptor on pancreatic plasma membranes (16, 17) and for cyclosomatostatin binding to the hepatocytes (9) . Sat0 et al. (10) used Krebs-Ringer bicarbonate buffer containing glucose and BSA without calcium salts; they observed no specific SS-14 binding to the liver cell surface (10) . This data further emphasizes the necessity of Ca+ + in any binding assay buffer. In isolated rat liver, it has been shown that 27% of SS-28 is converted to SS-14 (21) . Conlon et al. observed less than 10% degradation of 1251-[tyr11]SS-14 when it was exposed to hepatocytes in uitro (22) . In this study, we used 20 pg of the membranes at 24" C and have recovered 92% of the radioactivity as intact tracer as measured by Sephadex G-50 column chromatography. Taken together, the data suggest that isolated membranes are the best available model for the study of liver membrane SS-14 binding proteins (12, (15) (16) (17) .
Displacement of 1251-[tyr1']SS-14 with biologically active somatostatin analogs, but not by biologically inactive l-12SS-28 or other unrelated peptides, was demonstrated (Table 1) . Because SS-14 is thought to be the physiological ligand for the SS-14 receptor, the ability of SS-14 analogs to displace 1251-[tyr'11SS-14 was judged with SS-14 as the standard. Interestingly, [tyrl1]SS-14 and other tyrosinylated analogs were less capable of displacement of radioligand than was SS-14. SS-14 analogs modified in the ring portion of the molecule-especially at position 8, such as D-trp'-were more potent in displacing SS-14, in accordance with data reported in pancreatic acinar membranes (16) . The relative potency of each analog in inhibiting binding of 1261-[tyr1'lSS-14 to liver plasma membranes also correlated with known biological potency (Table 2; 16, 17, 21) . The data support the contention that binding of '251-[tyr111SS-14 to liver plasma membranes is specific.
To further characterize the nature of the SS-14 binding sites, 1251-[tyr11]SS-14 was cross-linked to binding sites on the rat liver plasma membranes with one homobifunctional and three heterobifunctional cross-linking reagents, as described previously, to study peptide hormone receptors (15, 16) . Of the four crosslinking reagents used, the homobifunctional reagent DSS was found to be the most efficient. The data are similar to that found for SS-14 binding in pancreas (16) . Our finding of a labeled band at mol wt 70,000 Da suggests that the binding site is a protein of 70,000 Da and similar to that reported by Ogawa (8) . Complete absence of this band in the presence of 10 FmoVL SS-14 further confirms the saturability of the binding (Fig. 3) . Identification of the band in the same position in presence of the reducing agent DTT also suggests that the SS-14 binding protein does not contain sulfhydryl linkages or subunits (15) . The meaning of observed variations in the reported size of SS-14 receptors is unknown; however, the finding of an SS-14 binding protein with an approximate mol wt 70,000 Da in this study, one of 92,000 Da in pancreas (17) and another of 60,000 Da in brain (23) could be due to alternative messenger RNA processing or posttranslational processing of a common protein (24, 25) . Such molecular 439 variations might explain functional differences in SS-14 receptor subtypes (26, 27) .
The band of cross-linked radloactivity is somewhat broad (Fig. 3) and suggests that it is a glycoprotein (28) . To further investigate the possibility that sugar moieties were present, the cross-linked, radiolabeled binding protein was first solubilized in nondenaturing detergents. Zwittergent 3-12 and CHAPS were most efficient, similar to findings in pancreatic and brain membranes (15, 23) . Adsorption of the cross-linked SS-14 binding protein by WGA-agarose columns and elution by a competing sugar, N, N' , N"-triacetylchitotriose (Fig. 41, suggest that the cross-linked SS-14 binding protein is indeed a glycoprotein and supports previous observations that a broad band on SDS-PAGE is an indication of the presence of glycosylation (28). No increased migration of the radioactive band is seen on SDS-PAGE, despite the loss of binding to WGA columns after endo F treatment of DSS cross-linked 1251-[tyr1 'ISS-14 binding proteins, suggesting that the SS-14 binding protein is only sparsely glycosylated with mannose oligosaccharides to a degree not resolvable by PAGE (18) .
In summary, we showed that the specific binding of
1251-[tyr11]SS-14
to liver plasma membranes is inhibited by the presence of GMP, GDP, GTP and GTP with pyruvate kinase (Fig. 7A) , suggesting regulation by guanine nucleotide binding proteins (G proteins). The data support the hypothesis that G proteins may mediate SS-14-inhibited cyclic AMP synthesis in hepatocytes (4). The potential interaction of the 1251-[tyr1'lSS-14 binding protein with G proteins is further supported by the observation of increasing inhibition of binding of 1261-[tyr1']SS-14 to liver plasma membranes in the presence of GTPyS (Fig. 7B) . The demonstration of a SS-14-specific, saturable, hepatocyte membrane binding protein; the biochemical characteristics; and the inhibition of binding by guanine nucleotides all suggest that this protein functions as a hepatic SS-14 receptor.
